Assessing how patient feedback affects treatment adjustments for autoimmune diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the impact of electronic Patient Reported Outcomes (ePROs) on the management of patients with gout, rheumatoid arthritis, Sjogren's syndrome, or systemic lupus erythematosus. By collecting regular feedback from patients through ePROs, physicians can make informed therapeutic adjustments based on the latest patient data. The study aims to determine if this approach leads to more effective treatment strategies and improved patient outcomes. The data collected will be communicated to physicians without interpretation, allowing for timely adjustments in therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Men or women of at least 18 years of age
* Diagnosed with (at least) one of the following autoimmune diseases:

  * Rheumatoid arthritis (RA) according to the 2010 EULAR/ACR classification criteria,
  * Gout according to the 2015 EULAR/ACR classification criteria,
  * Systemic lupus erythematosus according to the 2019 EULAR/ACR classification criteria
  * Sjogren's Syndrome according to the 2016 EULAR/ACR classification criteria
* According to local regulations, patient has expressed his/her non-opposition (for France) or has provided written informed consent (for Switzerland and Germany) to participate in the study
* Patient has access to the internet, a functioning email address and a mobile phone number
* Patient physically and mentally able to use a computer tool connected to the Internet
* Only in Switzerland \& Germany : patient is covered by a health insurance plan

Exclusion Criteria:

* Any neurodegenerative disease that alters cognitive faculties
* Refractory cancer
* Patients who do not have access to the Internet and/or do not master its use in the context of this protocol
* Unwillingness or inability to adhere to study protocol (language barriers, cognitive disorders…) Subject who is compulsorily detained for psychiatric treatment
* Patient who cannot be followed for 2 years by the investigating physician
* Patient over the age of legal majority who is protected, or deprived of liberty by judicial or administrative decision (vulnerable subject)
* Patient with an estimated life expectancy shorter than 1 year

Where it's running

• University Hospital of Strasbourg
  Strasbourg, France Recruiting

Study contacts

• Study coordinator: Jacques-Eric GOTTENBERG, Professor
• Email: jacques-eric.gottenberg@chru-strasbourg.fr
• Phone: 3 88 12 79 53

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Creating Health online course for people with rheumatological conditions

  This project will test whether an online course about diet and self-care helps adults with rheumatoid arthritis, Sjogren's syndrome, lupus, mixed connective tissue disease, or psoriatic arthritis reduce fatigue and improve quality of life.

  Recruiting University of Iowa · Iowa City, Iowa · NCT07180537

• Registry and biorepository for rheumatic diseases

  This study is collecting samples and health information from adults with rheumatic diseases at Yale clinics to help researchers learn more about these conditions and improve future treatments.

  Recruiting Yale University · New Haven, Connecticut · NCT04402086

• Registry for pregnant women with autoimmune diseases

  This study is trying to learn more about how autoimmune diseases affect pregnant women and their babies to help improve their health during and after pregnancy.

  Recruiting Duke University · Durham, North Carolina · NCT03276923

• Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people

  This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07829497

• First-in-human test of CND319 in healthy people and people with rheumatic diseases

  This early study tests whether CND319 is safe and tolerable and whether it shows any signs of activity in healthy adults and in people with rheumatoid arthritis or Sjogren's syndrome.

  Recruiting Phase 1 Candid Therapeutics · Melbourne, Victoria · NCT07712939

• Test of HBM7020 in healthy adults and adults with autoimmune diseases

  This first-in-human study tests whether HBM7020 is safe and how it acts in the body for people with autoimmune diseases like RA, SLE, Sjögren's, and SSc compared with healthy volunteers.

  Recruiting Phase 1 Otsuka Pharmaceutical Development & Commercialization, Inc. · Brisbane, Queensland · NCT07649265

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.